Oppenheimer downgraded Imperva (NASDAQ: IMPV) from Outperform to Perform.Analyst Shaul Eyal offers three reasons for the downgrade:We clearly understand IMPV's ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE